Cargando…

Supply chain transparency and the availability of essential medicines

Detalles Bibliográficos
Autores principales:	Årdal, Christine, Baraldi, Enrico, Beyer, Peter, Lacotte, Yohann, Larsson, DG Joakim, Ploy, Marie-Cécile, Røttingen, John-Arne, Smith, Ingrid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Health Organization 2021
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085627/ https://www.ncbi.nlm.nih.gov/pubmed/33953450 http://dx.doi.org/10.2471/BLT.20.267724

Ejemplares similares

Financing Pull Mechanisms for Antibiotic-Related Innovation: Opportunities for Europe
por: Årdal, Christine, et al.
Publicado: (2020)

Infection prevention and control research priorities: what do we need to combat healthcare-associated infections and antimicrobial resistance? Results of a narrative literature review and survey analysis
por: Lacotte, Yohann, et al.
Publicado: (2020)

National Facilitators and Barriers to the Implementation of Incentives for Antibiotic Access and Innovation
por: Årdal, Christine, et al.
Publicado: (2021)

Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations
por: Årdal, Christine, et al.
Publicado: (2018)

Open Source Drug Discovery in Practice: A Case Study
por: Årdal, Christine, et al.
Publicado: (2012)

An Open Source Business Model for Malaria
por: Årdal, Christine, et al.
Publicado: (2015)

Financing and collaboration on research and development for nodding syndrome
por: Årdal, Christine, et al.
Publicado: (2016)

Opening access to the black box: The need for reporting on the global phosphorus supply chain
por: Nedelciu, Claudiu-Eduard, et al.
Publicado: (2019)

A New Deal for Global Health R&D? The Recommendations of the Consultative Expert Working Group on Research and Development (CEWG)
por: Røttingen, John-Arne, et al.
Publicado: (2012)

Common characteristics of open source software development and applicability for drug discovery: a systematic review
por: Årdal, Christine, et al.
Publicado: (2011)

Transparency and sustainability in global commodity supply chains
por: Gardner, T.A., et al.
Publicado: (2019)

Introduction and geographic availability of new antibiotics approved between 1999 and 2014
por: Kållberg, Cecilia, et al.
Publicado: (2018)

Mineral Raw Material Supply Chain Transparency and Traceability: Does Provenance Matter in the Supply Chain?
por: Dietrich, Valentina, et al.
Publicado: (2022)

The Impact of Social Capital on Socially Responsible Supply Chain Performance: The Moderating Role of Supply Chain Transparency
por: Liu, Hua, et al.
Publicado: (2023)

Where is the policy in health policy and systems research agenda?
por: Ghaffar, Abdul, et al.
Publicado: (2016)

An antibiotic’s journey from marketing authorization to use, Norway
por: Årdal, Christine, et al.
Publicado: (2017)

Building resilient medical technology supply chains with a software bill of materials
por: Carmody, Seth, et al.
Publicado: (2021)

PPE Supply Chain Needs Data Transparency and Stress Testing
por: Dai, Tinglong, et al.
Publicado: (2020)

Essentials of supply chain management
por: Hugos, Michael H
Publicado: (2011)

Essentials of Supply Chain Management
por: Hugos, Michael
Publicado: (2018)

TC10 as an essential molecule in axon regeneration through membrane supply and microtubule stabilization
por: Nakamura, Takeshi, et al.
Publicado: (2021)

Building resilient health-care supply chains to manage pandemics in low- and middle-income countries
por: Fernandes, Genevie, et al.
Publicado: (2022)

Lean Supply Chain Management Essentials
por: Kerber, Bill, et al.
Publicado: (2017)

The knock-on effects of COVID-19 pandemic on the supply and availability of generic medicines in Ethiopia: mixed methods study
por: Mekonnen, Zeleke, et al.
Publicado: (2023)

Bulletin comment: Openness, transparency and candour(†)
Publicado: (2014)

Grant Application Review: The Case of Transparency
por: Gurwitz, David, et al.
Publicado: (2014)

The Transformative Nature of Transparency in Research Funding
por: Mietchen, Daniel
Publicado: (2014)

Accountability and Transparency: A Nuanced Response to Etzioni
por: Ferry, Laurence, et al.
Publicado: (2015)

Availability and use of Standards in vaccine development
por: Avumegah, Michael Selorm, et al.
Publicado: (2023)

Adapting environmental surveillance for polio to the need to track antimicrobial resistance
por: Årdal, Christine, et al.
Publicado: (2021)

APICS dictionary: the essential supply chain reference
por: Apics
Publicado: (2013)

Assumptions in ecosystem service assessments: Increasing transparency for conservation
por: Schröter, Matthias, et al.
Publicado: (2020)

A call for transparency in tracking student and postdoc career outcomes
por: Polka, Jessica K., et al.
Publicado: (2015)

Publication planning: promoting an ethics of transparency and integrity in biomedical research
por: DeTora, L., et al.
Publicado: (2015)

Transparency in authors’ contributions and responsibilities to promote integrity in scientific publication
por: McNutt, Marcia K., et al.
Publicado: (2018)

Reporting bias in clinical trials: Progress toward transparency and next steps
por: Mitra-Majumdar, Mayookha, et al.
Publicado: (2022)

An implementation framework to improve the transparency and reproducibility of computational models of infectious diseases
por: Pokutnaya, Darya, et al.
Publicado: (2023)

Continuity in Drinking Water Supply
por: Brocklehurst, Clarissa, et al.
Publicado: (2015)

Machine learning for tumor growth inhibition: Interpretable predictive models for transparency and reproducibility
por: Meid, Andreas D., et al.
Publicado: (2022)

Moving Health Literacy Research and Practice towards a Vision of Equity, Precision and Transparency
por: Guo, Shuaijun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lekc5v30tsqfckngjijrmacp3a